COVID-19 - October 12, 2020
AstraZeneca’s AZD7442 advances into Phase III
Two trials of AZD7442 will enrol over 6,000 adults for the prevention of COVID-19 with additional trials enrolling ~4,000 adults for the treatment of SARS-CoV-2 infections. The US Government to invest ~$486m for development and supply of up to 100,000 doses and can acquire another one million doses, states AstraZeneca. Phase III clinical trials AstraZeneca’s […]
COVID-19 - October 6, 2020
AstraZeneca’s vaccine trial resumed in Japan
The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). A standard review process triggered a voluntary pause to vaccination across all global trials on 6 September to allow review of safety data by an independent committee. Their recommendations have […]
COVID-19 - October 6, 2020
Nitric oxide – possible treatment for COVID-19
Researchers at Uppsala University have found that an effective way of treating the coronavirus behind the 2003 SARS epidemic also works on the closely related SARS-CoV-2 virus. The substance concerned is nitric oxide (NO), a compound with antiviral properties that is produced by the body itself. The study is published in the journal Redox Biology. […]
COVID-19 - October 5, 2020
New insights on how our immune system responds against COVID-19 infection
A type of anti-bacterial T cells, so-called MAIT cells, are strongly activated in people with moderate to severe COVID-19 disease, according to a study by researchers at Karolinska Institutet. The research is published in the journal Science Immunology. “To find potential treatments against COVID-19, it is important to understand in detail how our immune system […]
COVID-19 - September 29, 2020
Antibiotics seldom necessary for COVID-19 patients shows Danish research
Danish research shows that people with COVID-19 who are hospitalized rarely have bacterial infections and antibiotics are therefore not needed at admission. About 95% of the people hospitalized with COVID-19 are treated immediately with antibiotics. The reasons include sky-high infection biomarkers, blood test parameters that are completely skewed and X-rays seemingly indicating typical pneumonia. However, […]
COVID-19 - September 29, 2020
Lipigon signs agreement with universities in Shanghai and Shenzhen
Lipigon Pharmaceuticals has signed agreements with the two universities to develop a new drug that can potentially reduce the number of deaths linked to COVID-19. The Umeå-based company has signed an agreement with Nanyang Technological University in Singapore and Shenzhen to test whether one of its drug candidates, which blocks a protein that is very […]
